Gastrointestinal Therapeutics Market Size, Share & Industry Analysis, By Product Type (Small Molecules/Conventional Drugs and Biologics & Biosimilars), By Therapy Type (Acid Suppression Therapies {Proton Pump Inhibitor (PPI) and Others}, Targeted Therapies {Antibodies, JAK Inhibitors, and Others}, Anti-Inflammatory & Immunomodulators, Antibiotics, Antiemetics, Motility Agents & Secretagogues, and Others), By Route of Administration (Oral, Parenteral, and Others), By Age Group (Pediatrics and Adults), By Application, By Distribution Channel, and Regional Forecast, 2025-2032

Last Updated: December 08, 2025 | Format: PDF | Report ID: FBI114337

To get information on various segments, share your queries with us

Report Scope & Segmentation

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2024
Forecast Period	2025-2032
Historical Period	2019-2023
Growth Rate	CAGR of 5.71% from 2025-2032
Unit	Value (USD Billion)
Segmentation	By Product Type Small Molecules/Conventional Drugs Biologics & Biosimilars By Therapy Type Acid Suppression Therapies Proton Pump Inhibitor (PPI) Others Targeted Therapies Antibodies JAK Inhibitors Others Anti-Inflammatory & Immunomodulators Antibiotics Antiemetics Motility Agents & Secretagogues Others By Route of Administration Oral Parenteral Others By Age Group Pediatrics Adults By Application Gastroesophageal Reflux Disease (GERD) Functional Gastrointestinal Disorders (FGIDs) Inflammatory Bowel Disease (IBD) Irritable Bowel Syndrome (IBS) GI Cancers Others By Distribution Channel Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies By Region North America (By Product Type, Therapy Type, Route of Administration, Age Group, Application, Distribution Channel, and Country) U.S. Canada Europe (By Product Type, Therapy Type, Route of Administration, Age Group, Application, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Product Type, Therapy Type, Route of Administration, Age Group, Application, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Product Type, Therapy Type, Route of Administration, Age Group, Application, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Product Type, Therapy Type, Route of Administration, Age Group, Application, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa